Rare diseases
Expansion into new international biotech markets can be challenging. Unfamiliar regulations and licensing, coupled with language and cultural differences, can all be barriers to growth. If you’re considering venturing into Europe and beyond, our easy-to-follow guides, shaped by 30 years of expertise in the rare disease market, will assist you in navigating challenges and gaining a profound understanding of the complexities involved in launching orphan drugs into new markets. To learn more about how Sciensus can facilitate and support your Europan expansion, visit: Rare Diseases and Orphan Drugs
Events, Rare diseases
We’re speaking at the Rare Trials Summit 2025
Case Studies, Rare diseases
How Sciensus supported the launch and distribution of a breakthrough therapy in Europe and beyond
Thought Leadership, Rare diseases
Powering rare disease access with real-world evidence
Thought Leadership, Rare diseases
A strategic framework for global access and personalised care
Blogs, Rare diseases
Driving reimbursement success in Europe with real-world data
Blogs, Rare diseases
Breaking into Europe: insights for biotech leaders
Thought Leadership, Rare diseases
Pharmacists and specialty pharmacies in rare disease commercialisation
Thought Leadership, Rare diseases
Key strategies for a successful European drug launch
Thought Leadership, Rare diseases
Commercialization of rare & orphan products in Switzerland and smaller EU Markets